FrancophonIA/ELRC3.0 huggingface dataset:
English: Preclinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, acute toxicity, local tolerance, contact-sensitising potential, and genotoxicity.
Slovenian: Predklinični podatki na podlagi običajnih študij farmakološke varnosti, akutne toksičnosti, lokalne tolerance, potenciala za izzivanje kontaktne preobčutljivostne reakcije in genotoksičnosti ne kažejo posebnega tveganja za ljudi.
English: During the dialysis sessions the mean half-life of plasma concentration decline was in the range 5-6 hours.
Slovenian: Med postopkom dialize je bila srednja vrednost razpolovnega časa zmanjšanja koncentracije v plazmi 5
English: NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER TMC Pharma Services Ltd., Finchampstead, Berkshire, RG40 4LJ, UK
Slovenian: IME IN NASLOV IMETNIKA DOVOLJENJA ZA PROMET Z ZDRAVILOM TMC Pharma Services Ltd., Finchampstead, Berkshire, RG40 4LJ, Velika Britanija
English: Ask your pharmacist how to dispose of medicines no longer required.
Slovenian: O načinu odstranjevanjazdravila, ki ga ne potrebujete več, se posvetujte s farmacevtom.
English: After first opening use immediately
Slovenian: Uporabite takoj po odprtju
English: 10 ml
Slovenian: VIALA 10 ml
English: The most common adverse reactions were pruritus, paresthesia, headache, nausea, vasodilatation, burning sensation and dysgeusia.
Slovenian: Najpogostejši neželeni učinki, povezani z uporabo kontrastnega sredstva, so bili pruritus, parestezija, glavobol, navzea, vazodilatacija, pekoč občutek in disgevzija.
English: 1, 5 or 10 injection vials with 10 ml solution for injection (in 10-ml glass vial) 1, 5 or 10 injection vials with 15 ml solution for injection (in 20-ml glass vial) 1, 5 or 10 injection vials with 20 ml solution for injection (in 20-ml glass vial) Not all pack sizes may be marketed.
Slovenian: 1, 5 ali 10 vial po 10 ml raztopine za injiciranje (v 10-mililitrskih steklenih vialah) 1, 5 ali 10 vial po 15 ml raztopine za injiciranje (v 20-mililitrskih steklenih vialah) 1, 5 ali 10 vial po 20 ml raztopine za injiciranje (v 20-mililitrskih steklenih vialah)
English: If you have any questions or are not sure about something, ask the doctor or MRI-centre personnel.
Slovenian: Če imate dodatna vprašanja ali če o čem niste povsem prepričani, se posvetujte z zdravnikom ali z osebjem oddelka za magnetnoresonančno slikanje.
English: Posology Adults: 0.12 ml/kg body weight (equivalent to 0.03 mmol/kg)
Slovenian: Odmerjanje: Odrasli: 0,12 ml/kg telesne mase (kar ustreza 0,03 mmol/kg)
English: ( 1/1,000 to  1/100)
Slovenian: (≥ 1 /1.000 do < 1 /100)
English: No studies on the effects on the ability to drive and use machine have been performed.
Slovenian: Študij vpliva kontrastnega sredstva na sposobnost vožnje in upravljanja s stroji niso izvedli.
English: Repeated dose toxicity
Slovenian: Toksičnost pri večkratnem odmerjanju
English: Relaxivity in plasma was measured to be 33.4 to 45.7 mM-1s-1 over the dose range of up to
Slovenian: Izmerjena relaksacija v plazmi je bila 33,4 do 45,7 mM-1s-1 pri odmerkih do 0,05 mmol/kg pri 20 MHz.
English: This medicinal product is for diagnostic use only.
Slovenian: To zdravilo je samo za diagnostične namene.
English: Hemodialysis patients
Slovenian: Bolniki na hemodializi:
English: Vials containing Ablavar are not intended for the withdrawal of multiple doses.
Slovenian: Viale z zdravilom Ablavar niso namenjene za večkratno odmerjanje.
English: There have been reports of nephrogenic systemic fibrosis (NSF) associated with use of some gadolinium-containing contrast agents in patients with acute or chronic severe renal impairment (GFR < 30 ml/min/1.73 m2).
Slovenian: Poročali so o nefrogeni sistemski fibrozi (NSF), povezani z uporabo nekaterih kontrastnih sredstev, ki vsebujejo gadolinij, pri bolnikih z akutno ali kronično hudo ledvično okvaro (hitrost glomerulne filtracije (GRF< 30 ml/min/1,73 m2).
English: please tell your doctor or radiologist.
Slovenian: Njegovo uporabo boste pretehtali z zdravnikom ali radiologom.
English: Scanning may start immediately after the Ablavar injection.
Slovenian: Slikanje lahko opravijo takoj po injiciranju Ablavar.
English: Ablavar is an injectable contrast medium for making a diagnostic image of the body's blood vessels in the abdomen or limb clearer.
Slovenian: Ablavar je kontrastno sredstvo za injiciranje, ki se uporablja pri diagnostičnem slikanju krvnih žil v trebuhu ali okončinah.
English: This medicine can uncommonly cause dizziness or vision problems.
Slovenian: Redko se pri jemanju tega zdravila lahko pojavijo vrtoglavica ali težave z vidom.
English: After withdrawal of the solution from the vial, it should be used immediately.
Slovenian: Ko raztopino vzamete iz viale, jo morate takoj porabiti.
English: SPECIAL STORAGE CONDITIONS Keep the injection vial in the outer carton in order to protect from light
Slovenian: POSEBNA NAVODILA ZA SHRANJEVANJE Vialo za injiciranje shranjujte v zunanji ovojnini za zagotovitev zaščite pred svetlobo.
English: Clear, colourless to pale yellow liquid.
Slovenian: raztopina za injiciranje bistra, brezbarvna do bledo rumena tekočina.
English: The dose is: 0.12 ml/kg body weight (equivalent to 0.03 mmol/kg of body weight).
Slovenian: Odmerek je: 0,12 ml/kg telesne mase (kar ustreza 0,03 mmol/kg telesne mase).
English: Protein binding enhances T1 relaxivity of gadofosveset up to 10 fold compared to non-protein bound gadolinium chelates.
Slovenian: Vezava na beljakovine v primerjavi z gadolinijevimi kelati, ki niso vezani na beljakovine, do 10- krat podaljša relaksacijski čas T1 gadofosveseta.
English: Important information about some of the ingredients of Ablavar This medicine contains 6.3 mmol sodium (or 145 mg) per dose.
Slovenian: Pomembne informacije o nekaterih sestavinah kontrastnega sredstva Ablavar To zdravilo vsebuje 6,3 mmol (ali 145 mg) natrija na odmerek.
English: The rubber stopper should never be pierced more than once.
Slovenian: Gumijasti zamašek lahko prebodete samo enkrat.
English: affects more than 1 user in 10 Common:
Slovenian: pojavijo se pri več kot 1 od 10 bolnikov
English: After intravenous administration of 0.03 mmol/kg dose renal clearance (5.51 ± 0.85 ml/h/kg) and total clearance (6.57 ± 0.97 ml/h/kg) were similar, and mean terminal elimination half-life was 18.5 ± 3.0 hours.
Slovenian: Po intravenski aplikaciji odmerka 0,03 mmol/kg sta bila ledvični očistek (5,51 ± 0,85 ml/h/kg) in skupni očistek (6,57 ± 0,97 ml/h/kg) podobna.
English: Ablavar can be removed by haemodialysis.
Slovenian: Ablavar se lahko odstrani s hemodializo.
English: Most of the adverse reactions were mild to moderate in intensity.
Slovenian: Neželeni učinki so bili večinoma blagi do zmerni.
English: This medicinal product should be administered as a single intravenous bolus injection, manually, or by magnetic resonance injector (MR injector) over a period of time up to 30 seconds followed by a 2530 ml normal saline flush.
Slovenian: Ta medicinski izdelek je treba odmerjati v obliki enkratne intravenske bolusne injekcije, ročno ali z injektorjem za MR (magnetno resonance) v času do 30 sekund, nato sledi izpiranje s 25-30 ml fiziološke raztopine.
English: In healthy volunteers, gadofosveset was predominantly eliminated in the urine with 84% (range 7994%) of the injected dose (0.03 mmol/kg) excreted in the urine in 14 days.
Slovenian: Pri tem se je 84 % (79 - 94 %) injiciranega odmerka (0,03 mmol/kg) v 14 dneh izločilo v urinu.
English: Plasma pharmacokinetics and protein binding of gadofosveset were not significantly influenced by moderate hepatic impairment (Child Pugh B).
Slovenian: Zmerno oslabljeno delovanje jeter ni vplivalo na farmakokinetiko gadofosveseta v plazmi in stopnjo vezave na beljakovine (Child Pugh B).
English: If you think you may have had an overdose talk to your doctor immediately.
Slovenian: Če ste prejeli večji odmerek Ablavar, kot bi smeli Če menite, da ste prejeli preveliki odmerek, se takoj posvetujte s svojim zdravnikom.
English: High resolution MRA scans of vascular structures are obtained up to one hour after administration of the medicinal product.
Slovenian: Slike visoke ločljivosti žilnih struktur z MRS se pridobijo v eni uri po aplikaciji kontrastnega sredstva.
English: The contents of the packs are:
Slovenian: Na voljo je v naslednjih pakiranjih:
English: - The other ingredients are fosveset, sodium hydroxide, hydrochloric acid, and water for injections.
Slovenian: - Pomožne snovi so fosveset, natrijev hidroksid, klorovodikova kislina in voda za injekcije.
English: TMC Pharma Services Ltd., Finchampstead, Berkshire RG40 4LJ , UK Tel:01252 842255
Slovenian: Imetnik dovoljenja za promet z zdravilom in izdelovalec TMC Pharma Services Ltd., Finchampstead, Berkshire RG40 4LJ, Velika Britanija Tel: +44 (0) 1252 842255
English: Uncommon ( 1/1,000 to  1/100)
Slovenian: Občasni (≥ 1 /1.000 do < 1 /100)
English: Abnormal sensation in eye Asthenopia
Slovenian: Očesne bolezni nenormalen občutek v očeh astenopija
English: The peel-off tracking label included on the vials should be stuck onto the patient record to enable accurate recording of the gadolinium contrast agent used.
Slovenian: Odluščljivo sledilno oznako, priloženo vialam, pritrdite na kartoteko bolnika, da zagotovite natančno evidentiranje uporabljenega kontrastnega sredstva z gadolinijem.
English: Keep out of the reach and sight of children.
Slovenian: Shranjevanje izven dosega in vidnega polja otrok.
English: Ablavar should be administered as a single intravenous bolus injection, manually, or by magnetic resonance injector over a period of time up to 30 seconds followed by a 25-30 ml normal saline flush.
Slovenian: Kontrastno sredstvo Ablavar je treba odmerjati v obliki enkratne intravenske bolusne injekcije, ročno ali z injektorjem za MR (magnetno resonance) v času do 30 sekund, nato sledi izpiranje s 25-30 ml fiziološke raztopine.
English: Keep the injection vial in the outer carton in order to protect from light.
Slovenian: Viale shranjujte v zunanji ovojnini za zagotovitev zaščite pred svetlobo.
English: Injury, poisoning and procedural complications
Slovenian: Poškodbe, zastrupitve in zapleti pri posegih fantomska bolečina v okončinah
English: EU/1/05/313/001 - 009
Slovenian: ŠTEVILKA(-E) DOVOLJENJA (DOVOLJENJ) ZA PROMET EU/1/05/313/001 - 009
English: 10 ml solution contains 2.27 g, 15 ml solution contains 3.41g and 20 ml solution contains 4.54 g
Slovenian: 10 ml raztopine vsebuje 2,27 g, 15 ml raztopine vsebuje 3,41 g in 20 ml raztopine vsebuje 4,54 g gadofosveseta v viali.
English: Cases of nephrogenic systemic fibrosis (NSF) have been reported with other gadolinium-containing contrast agents (see section 4.4).
Slovenian: Pri uporabi drugih kontrastnih sredstev, ki vsebujejo gadolinij, so poročali o primerih nefrogene sistemske fibroze (NSF) (glejte poglavje 4.4).
English: Prior to administration of Ablavar it is recommended that all patients are screened for renal dysfunction by obtaining laboratory tests.
Slovenian: Pred apliciranjem Ablavar je priporočljivo, da se pri vseh bolnikih opravijo laboratorijski testi, da se ugotovi delovanje ledvic.
English: Rare ( 1/10,000 to  1/1,000)
Slovenian: Redki (≥ 1 /10.000 do < 1 /1.000)
English: EXP
Slovenian: PSUR
English: Hypersensitivity warning
Slovenian: Opozorilo o preobčutljivosti
English: This medicine contains 6.3 mmol sodium (or 145 mg) per dose.
Slovenian: To zdravilo vsebuje 6,3 mmol natrija (ali 145 mg) na odmerek.
English: Prior to administration of Ablavar, it is recommended that all patients are screened for renal dysfunction by obtaining laboratory tests.
Slovenian: Pred apliciranjem zdravila Ablavar je priporočljivo, da se pri vseh bolnikih opravijo laboratorijski testi, da se ugotovi delovanje ledvic.
English: This medicinal product is supplied ready to use as a clear, colourless to pale yellow aqueous solution.
Slovenian: Zdravilo je na voljo v obliki pripravljene, bistre, brezbarvne do svetlo rumene vodne raztopine.
English: The high-flux dialysis filter was more efficient compared to the low-flux filter, therefore, use of a high-flux dialysis filter is recommended.
Slovenian: Priporoča se uporaba visokopretočnih filtrov za dializo, ker so bili učinkovitejši od nizkopretočnih.
English: Ablavar is supplied ready to use as a clear, colourless to pale yellow aqueous solution.
Slovenian: Ablavar je na voljo v obliki pripravljene, bistre, brezbarvne do svetlo rumene vodne raztopine.
English: - If you have further questions, please ask the doctor giving you Ablavar (the radiologist) or the hospital/MRI-centre personnel - If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet,
Slovenian: - Če imate dodatna vprašanja, se posvetujte z zdravnikom, ki vam daje Ablavar (radiologom), ali z bolnišničnim osebjem/osebjem oddelka za magnetnoresonančno slikanje.
English: Further information regarding the administration and handling of this medicine is given at the end of the leaflet.
Slovenian: Nadaljne navodila o uporabi in rokovanju s Ablavar so na koncu tega navodila za uporabo.
English: Electrocardiogram ST segment depression, Electrocardiogram T wave amplitude decreased
Slovenian: nenormalen elektrokardiogram srčna undulacija, srčna ishemija, bradikardija, atrijska fibrilacija palpitacije, depresija segmenta ST na elektrokardiogramu, zmanjšanje amplitude vala T
English: Haemodialysis shortly after Ablavar administration in patients currently receiving haemodialysis may be useful at removing Ablavar from the body.
Slovenian: Pri bolnikih zdravljenih s hemodializo je lahko hemodializa izvedena kmalu po uporabi Ablavar koristna za njegovo odstranitev iz telesa.
English: Ablavar can be associated with allergy-like reactions (anaphylactoid / hypersensitivity reactions) characterised by:
Slovenian: Če imate katere od naslednjih simptomov, se takoj posvetujte z zdravnikom: Ablavar je lahko povezan z alergijam podobnimi reakcijami (anafilaktoidne ali preobčutljivostne reakcije), za katere so značilne:
English: Tingling or numbness of the hands or feet Change of taste in mouth Burning sensation
Slovenian: Pogosti: glavobol ščemenje ali otrplost v rokah ali stopalih sprememba okusa v ustih pekoč občutek občutek toplote (vazolidacija) vključno z vročinskimi oblivi slabost srbečica občutek mraza
English: Anaphylactoid reaction Hypotension Arteriosclerosis
Slovenian: Žilne bolezni občutek mraza v perifernih anafilaktične reakcije, hipotenzija, arterioskleroza
English: Excipient This medicinal product contains 6.3 mmol sodium (or 145 mg) per dose.
Slovenian: Pomožna snov To zdravilo vsebuje 6,3 mmol natrija (ali 145 mg) na odmerek.
English: Atrioventricular block first Electrocardiogram QT
Slovenian: Srčne bolezni atrioventrikularni blok I. stopnje, podaljšan interval QT
English: After withdrawal of the solution from the vial, this medicinal product should be used immediately.
Slovenian: Po odvzemu raztopine iz viale morate zdravilouporabiti takoj.
English: After first opening, the medicine should be used immediately.
Slovenian: Ko embalažo odprete, morate zdravilo takoj uporabiti.
English: It has not been proven that this medicine is safe to use during pregnancy.
Slovenian: Ni dokazov, da bi bila uporaba Ablavar med nosečnostjo varna.
English: NAME OF THE MEDICINAL PRODUCT Ablavar 0.25 mmol/ml solution for intravenous use
Slovenian: IME ZDRAVILA Ablavar 0,25 mmol/ml raztopina za intravenozno uporabo
English: Respiratory, thoracic and mediastinal disorders
Slovenian: Bolezni dihal, prsnega koša in mediastinalnega prostora depresija dihanja
English: Sodium hydroxide Hydrochloric acid Water for injection
Slovenian: fasoveset natrijev hidroksid klorovodikova kislina voda za injiciranje raztopina za injiciranje 20 ml
English: Ablavar 0.25 mmol/ml solution for injection Gadofosveset
Slovenian: Ablavar 0,25 mmol/ml raztopina za injiciranje gadofosveset
English: Vascular disorders Vasodilatation
Slovenian: Žilne opornice
English: Hyperglycaemia Electrolyte imbalance (incl.
Slovenian: Presnovne in prehranske motnje hiperglikemija, porušeno ravnovesje elektrolitov (tudi hipokalciemija),
English: Heartbeat irregularity/disturbed heart-chamber contractions (cardiac flutter, atrial fibrillation) problems with the electrical rhythm of the heart (ST segment/T wave abnormalities) Chest pain
Slovenian: Redki: vnetje kože okužbe sečil nenavadne sanje videnje, občutenje ali slišanje stvari zmanjšanje apetita motnje vida nenormalen občutek v očeh bolečine v ušesih nepravilnosti srčnega utripa/nenormalno krčenje srca (srčna undulacija, atrijska fibrilacija) spremembe v elektrokardiogramu (nepravilnosti ST-segmenta/T-vala)
English: Your doctor will treat you should overdose occur.
Slovenian: Zdravnik vas bo ustrezno zdravil.
English: Excipients: fosveset, sodium hydroxide, hydrochloric acid, water for injections See the leaflet for further information.
Slovenian: Pomožne snovi: fosveset, natrijev hidroksid, klorovodikova kislina, voda za injekcije.
English: 1 ml contains 227 mg gadofosveset equivalent to 244 mg/ml (0.25 mmol/millilitre) gadofosveset trisodium.
Slovenian: 1 ml vsebuje 227 mg gadofosveseta v obliki 244 mg/ml (0,25 mmol/ml) trinatrijevega gadofosveseta.
English: Chest pressure sensation Injection site thrombosis Injection site bruising Injection site inflammation Injection site burning Injection site extravasation Injection site haemorrhage Injection site pruritus Sensation of pressure
Slovenian: pireksija, mrazenje (mrzlica), oslabelost, občutek stiskanja v prsnem košu, tromboza na mestu injiciranja, modrice na mestu injiciranja, vnetje na mestu injiciranja, pekoč občutek na mestu injiciranja, ektravazacija na mestu injiciranja, krvavitve na mestu injiciranja, srbenje na mestu injiciranja, občutek pritiska
English: NAME OF THE MEDICINAL PRODUCT Ablavar 0.25 mmol/ml solution for injection
Slovenian: IME ZDRAVILA Ablavar 0,25 mmol/ml raztopina za injiciranje
English: After first opening: the medicinal product should be used immediately.
Slovenian: Po prvem odprtju: kontrastno sredstvo morate uporabiti takoj po odprtju.
English: Injection site pain, Injection site erythema, Injection site
Slovenian: Splošne težave in spremembe na mestu uporabe bolečine na mestu injiciranja, eritem na mestu injiciranja,
English: MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS 10 ML
Slovenian: PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH
English: Genital itching
Slovenian: Ookvara jeter
English: Hyperkalemia Hypokalemia Hypernatremia Appetite decreased
Slovenian: hiperkaliemija hipokaliemija hipernatriemija
English: Cellulitis Urinary tract infection
Slovenian: Infekcijske in parazitske bolezni nazofaringitis celulitis okužbe sečil
English: Each vial of 10 ml solution contains a total of 2.44 g (2.50 mmol) of gadofosveset trisodium equivalent to 2.27 g of gadofosveset
Slovenian: Ena viala z 10 ml raztopine vsebuje skupno 2,44 g (2,50 mmol) trinatrijevega gadofosveseta, kar ustreza 2,27 g gadofosveseta.
English: 1, 5, or 10 vials  15 ml (in 20-ml glass vial)
Slovenian: 1, 5 ali 10 vial × 10 ml (v 10-mililitrski stekleni viali) 1, 5 ali 10 vial × 15 ml (v 20-mililitrski stekleni viali) 1, 5 ali 10 vial × 20 ml (v 20-mililitrski stekleni viali)
English: Pharmacovigilance Plan or risk minimisation activities
Slovenian: Sistem farmakovigilance
English: Each vial of 10 ml solution contains 2.44 g (2.50 mmol) of gadofosveset trisodium equivalent to 2.27g gadofosveset.
Slovenian: Ena viala z 10 ml raztopine vsebuje 2,44 g (2,50 mmol) trinatrijevega gadofosveseta, kar ustreza 2,27 g gadofosveseta.
English: Hallucination Abnormal dreams
Slovenian: Psihiatrične motnje anksioznost, zmedenost halucinacije nočne more
English: Impairment of taste
Slovenian: zmanjšan apetit
English: Each vial of 15 ml solution contains a total of 3.66 g (3.75 mmol) of gadofosveset trisodium equivalent to 3.41g of gadofosveset.
Slovenian: Ena viala z 15 ml raztopine vsebuje skupno 3,66 g (3,75 mmol) trinatrijevega gadofosveseta, kar ustreza 3,41 g gadofosveseta.
English: Each vial of 15 ml solution contains 3.66 g (3.75 mmol) of gadofosveset trisodium equivalent to 3.41 g of gadofosveset.
Slovenian: Ena viala s 15 ml raztopine vsebuje 3,66 g (3,75 mmol) trinatrijevega gadofosveseta, kar ustreza 3,41 g gadofosveseta.
English: Contrast media should not be used in case of severe discolouration, the occurrence of particulate matter, or defective container.
Slovenian: Če je kontrastno sredstvo izrazito obarvano, če vsebuje delce ali je poškodovan vsebnik, se ga ne sme uporabiti.
English: 15 ml
Slovenian: VIALA 15 in 20 ml
English: Each vial of 20 ml solution contains a total of 4.88 g (5.00 mmol) of gadofosveset trisodium equivalent to 4.54g of gadofosveset.
Slovenian: Ena viala z 20 ml raztopine vsebuje skupno 4,88 g (5,00 mmol) trinatrijevega gadofosveseta, kar ustreza 4,54 g gadofosveseta.
English: Each vial of 20 ml solution contains 4.88 g (5.00 mmol) of gadofosveset trisodium equivalent to 4.54 g of gadofosveset.
Slovenian: Ena viala z 20 ml raztopine vsebuje 4,88 g (5,00 mmol) trinatrijevega gadofosveseta, kar ustreza 4,54 g gadofosveseta.
English: 1 ml Ablavar solution for injection contains 244 mg (0.25 mmol) gadofosveset trisodium equivalent to 227 mg gadofosveset..
Slovenian: 1 ml Ablavar raztopine za injiciranje vsebuje 244 mg (0,25 mmol) trinatrijevega gadofosveseta, kar ustreza 227 mg gadofosveseta.
English: Gadofosveset
Slovenian: - Učinkovina je trinatrijev gadofosveset.
English: 1 ml Ablavar solution contains 244 mg (0.25 mmol) gadofosveset trisodium equivalent to 227 mg of gadofosveset.
Slovenian: 1 ml raztopine Ablavar vsebuje 244 mg (0,25 mmol) trinatrijevega gadofosveseta, kar ustreza 227 mg gadofosveseta..
English: GENERAL CLASSIFICATION FOR SUPPLY Medicinal product subject to medical prescription
Slovenian: NAČIN IZDAJANJA ZDRAVILA Predpisovanje in izdaja zdravila je le na recept
English: Decreased feeling or sensitivity of the lips Increased production of saliva Anal itching
Slovenian: povečano izločanje sline, dispepsija, suha usta, srbenje okoli anusa
English: Elderly (aged 65 years and above)
Slovenian: Starejši bolniki (stari 65 in več let) Prilagoditev odmerka ni potrebna.
English: EXP After first opening: the medicinal product should be used immediately.
Slovenian: DATUM IZTEKA ROKA UPORABNOSTI ZDRAVIL EXP Uporabite takoj po prvem odprtju.
English: Genital burning sensation Pain
Slovenian: Motnje reprodukcije in dojk genitalni pruritus, pekoč občutek v spolovilih bolečine v medenici
English: Marketing Authorisation Holder and Manufacturer
Slovenian: A. IMETNIK DOVOLJENJA ZA IZDELAVO ZDRAVILA,
English: EU/1/05/313/007 Ablavar-0.25 mmol/ml-Solution for injection-Intravenous use-Vial (glass)-20ml-1 vial
Slovenian: EU/1/05/313/007 Ablavar 0,25 mmol/ml raztopina za injiciranje - intravenska uporaba - viala (steklo) - 20 ml - 1 viala
English: Method of administration
Slovenian: Način odmerjanja
English: EU/1/05/313/008 Ablavar-0.25 mmol/ml-Solution for injection-Intravenous use-Vial (glass)-20ml-5 vials
Slovenian: EU/1/05/313/008 Ablavar 0,25 mmol/ml raztopina za injiciranje - intravenska uporaba - viala (steklo) - 20 ml - 5 vial
English: EU/1/05/313/004 Ablavar-0.25 mmol/ml-Solution for injection-Intravenous use-Vial (glass)-15ml-1 vial
Slovenian: EU/1/05/313/004 Ablavar 0,25 mmol/ml raztopina za injiciranje - intravenska uporaba - viala (steklo) - 15 ml - 1 viala
English: EU/1/05/313/009 Ablavar-0.25 mmol/ml-Solution for injection-Intravenous use-Vial (glass)-20ml-10 vials
Slovenian: EU/1/05/313/009 Ablavar 0,25 mmol/ml raztopina za injiciranje - intravenska uporaba - viala (steklo) - 20 ml - 10 vial
English: EU/1/05/313/005 Ablavar-0.25 mmol/ml-Solution for injection-Intravenous use-Vial (glass)-15ml-5 vials
Slovenian: EU/1/05/313/005 Ablavar 0,25 mmol/ml raztopina za injiciranje - intravenska uporaba - viala (steklo) - 15 ml - 5 vial
English: EU/1/05/313/006 Ablavar-0.25 mmol/ml-Solution for injection-Intravenous use-Vial (glass)-15ml-10 vials
Slovenian: EU/1/05/313/006 Ablavar 0,25 mmol/ml raztopina za injiciranje - intravenska uporaba - viala (steklo) - 15 ml - 10 vial
English: EU/1/05/313/001 Ablavar-0.25 mmol/ml-Solution for injection-Intravenous use-Vial (glass)-10 ml-1 vial
Slovenian: EU/1/05/313/001 Ablavar 0,25 mmol/ml raztopina za injiciranje - intravenska uporaba - viala (steklo) - 10 ml - 1 viala